Medicus Pharma (MDCX) Stock: Buy, Sell, or Hold?
$1.95
+0.23 (+13.37%)
▲
5d:
+4.28%
30d:
-43.15%
90d:
+650.0%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (92%)
Quality Score
63/100
Position
FAIR
30-Day Fair Range
$1.26 – $3.04
Position: FAIR
Forward P/E & Valuation
-0.1x
Next 12M consensus est.
Wall Street Target
$171.67
+8703.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.63 / $2.16
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: MDCX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When MDCX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: MDCX is currently trading at $1.95, which is considered fair relative to its 30-day fair value range of $1.26 to $3.04.
Technical Outlook: Technically, MDCX is in a strong uptrend. Immediate support is located at $1.63, while resistance sits at $2.16. The stock is showing strong short-term momentum, up 13.4% recently.
Market Sentiment: MDCX scores 83/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $171.67 (+8703.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MDCX is in a strong uptrend. Immediate support is located at $1.63, while resistance sits at $2.16. The stock is showing strong short-term momentum, up 13.4% recently.
Market Sentiment: MDCX scores 83/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $171.67 (+8703.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.26 -
$3.04
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
92.1%
Trading Range & Key Levels
30-Day Trading Range
$1.26 -
$3.04
Current vs Trading Range
FAIR
Support Level
$1.63
Resistance Level
$2.16
Current Trend
Strong Uptrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (83/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+13.4%)
- BULLISH: Trading 8703.4% below Wall St target ($171.67)
- CAUTION: Bottoming setup, but lagging the sector by 30% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
-0.14
Wall Street Target
$171.67
(+8703.4%)
Share MDCX Analysis
Share this live MDCX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (MDCX)
Neutral
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 4, 2026
Daily AI digest
AI Retail Discussion Summary:
No recent news articles found for $MDCX. StockTwits sentiment is bullish with 100.0% of messages expressing positive sentiment.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 15, 2026 12:21 AM ET
Data refreshes hourly during market hours. Next update: 1:21 AM
Data refreshes hourly during market hours. Next update: 1:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDCX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1453 | 39 SELL |
|
ABBV
AbbVie Inc |
STRONG BUY
29 analysts |
$306 | 49 HOLD |
|
GILD
Gilead Sciences Inc |
STRONG BUY
28 analysts |
$175 | 47 HOLD |
|
MRK
Merck & Company Inc |
BUY
28 analysts |
$162 | 53 HOLD |
|
BIIB
Biogen Inc |
BUY
36 analysts |
$266 | 41 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MDCX Research Pages
